GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Price-to-Owner-Earnings

LakeShore Biopharma Co (LakeShore Biopharma Co) Price-to-Owner-Earnings : (As of Jun. 05, 2024)


View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Price-to-Owner-Earnings?

As of today (2024-06-05), LakeShore Biopharma Co's share price is $0.8259. LakeShore Biopharma Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for LakeShore Biopharma Co's Price-to-Owner-Earnings or its related term are showing as below:


LSB's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 34.035
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-05), LakeShore Biopharma Co's share price is $0.8259. LakeShore Biopharma Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.57. Therefore, LakeShore Biopharma Co's PE Ratio for today is At Loss.

As of today (2024-06-05), LakeShore Biopharma Co's share price is $0.8259. LakeShore Biopharma Co's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.69. Therefore, LakeShore Biopharma Co's PE Ratio without NRI for today is At Loss.


LakeShore Biopharma Co Price-to-Owner-Earnings Historical Data

The historical data trend for LakeShore Biopharma Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Price-to-Owner-Earnings Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23
Price-to-Owner-Earnings
- - -

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Price-to-Owner-Earnings Get a 7-Day Free Trial - - - - -

Competitive Comparison of LakeShore Biopharma Co's Price-to-Owner-Earnings

For the Biotechnology subindustry, LakeShore Biopharma Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LakeShore Biopharma Co's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Price-to-Owner-Earnings falls into.



LakeShore Biopharma Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

LakeShore Biopharma Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.8259/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LakeShore Biopharma Co  (NAS:LSB) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


LakeShore Biopharma Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Traded in Other Exchanges
Address
38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.